A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.
Key Details
- 1Published in American Journal of Roentgenology; study compares radiologist performance with and without AI support.
- 2First prospective real-world evidence addressing limitations of prior retrospective research on AI in lung cancer screening.
- 3Study involved consecutive asymptomatic patients undergoing low-dose chest CT from May to September 2025.
- 4Patients were randomized to AI-assisted interpretation or radiologist-only reading arms.
- 5Primary outcomes measured: interpretation times and nodule detection rates, with secondary analysis on follow-up recommendations.
Why It Matters
Prospective, real-world data are essential for validating AI performance beyond retrospective analyses. The results support integrating AI into routine lung cancer screening, potentially improving early lung cancer detection and workflow efficiency.
Source
Radiology Business
Related News
•Radiology Business
Aidoc Raises $150M to Expand Imaging AI Portfolio and Global Reach
Aidoc secures $150M in Series E funding led by Goldman Sachs to accelerate expansion of its clinical AI platform.
•Radiology Business
AI Model Outperforms Radiologists in Early Pancreatic Cancer Detection
REMOD, a new AI model, detects pancreatic cancer on CT scans much earlier and more accurately than radiologists.
•Radiology Business
AI Model Identifies Colorectal Cancer on Routine Noncontrast CT Scans
Researchers introduce the COCA AI tool to detect colorectal cancer opportunistically on routine noncontrast CT scans.